Performance analysis of Leica Biosystems p16 monoclonal antibody in oropharyngeal squamous cell carcinoma
Abstract Background Head and neck squamous cell carcinoma (HNSCC) is the sixth leading cause of cancer death globally, with newly diagnosed oropharyngeal squamous cell carcinoma (OPSCC) cases rising to 54,000 in the US alone in the year 2022. Recently, human papilloma virus (HPV) infection was more...
Saved in:
Main Authors: | Selvam Thavaraj, Max Robinson, Shubham Dayal, Claire Bowen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Diagnostic Pathology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13000-025-01601-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Survival outcomes of marijuana users in p16 positive oropharynx cancer patients
by: Han Zhang, et al.
Published: (2019-09-01) -
EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma
by: Shanmugappiriya Sivarajah, et al.
Published: (2019-01-01) -
Immunoexpression of P16 and Ki 67 in oral squamous cell carcinoma: Association with clinicopathological parameters.
by: Shadan Mohamad Omer, et al.
Published: (2020-12-01) -
Knowledge and attitude among Egyptian medical students regarding the role of human papillomavirus vaccine in prevention of oropharyngeal cancer: a questionnaire-based observational study
by: Mohammed. N. Abdelaziz, et al.
Published: (2025-01-01) -
Clinical, histopathological and immunohistochemical analysis of vulvar squamous cell carcinoma
by: Lorenza Bridi Todeschini, et al.
Published: (2025-01-01)